Author Archives: Admin

Kraig Biocraft Laboratories Closes Additional Funding Agreement

Robust financial strength positions Company to deploy Impact Capital

ANN ARBOR, Mich., – January 20, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces the completion of an additional $3 million funding agreement with Yorkville Advisors (“Yorkville”). These additional funds, together with those from the previously announced transactions, account for an $8 million total Yorkville investment into Kraig Labs.

As a result of this successful capitalization program, the Company has elected not to renew the previously anticipated reverse stock split. The Company is focused on advancing the commercialization of spider silk. Kraig Labs will increase its capital deployment into key priorities, including commercialization, advanced research and development, and expansion at the Prodigy Textiles factory.

“This funding allows us to advance our strategic plans and transform our resources into more robust operations. We will immediately invest these capital expenditures to accelerate commercialization at Prodigy Textiles production facilities,” stated Company COO, Jon Rice.

Maxim Group LLC acted as the sole placement agent for this capital raise.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories Prepares to Ship Finished Dragon Silk Yarn From Vietnam Factory

ANN ARBOR, Mich., – January 18, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces it has completed production of the first Dragon Silk yarn produced entirely in Vietnam. The finished recombinant spider silk yarn was spun from raw spider silk produced at Prodigy Textiles, the Company’s subsidiary located in Quang Nam province, Vietnam. 

Today’s announcement marks a significant milestone for Kraig Labs, Prodigy Textiles, and the large-scale production of recombinant spider silk. This production run of Dragon Silk exhibits Prodigy Textiles’ full integration into Vietnam’s substantial silk textile industry. Vietnam produced nearly 1,000 metric tons of mundane silk in 2020.[1]  This same supply chain was used, from start to finish, to create the first Dragon Silk made entirely in Vietnam.

While Prodigy Textiles remains focused on ramping up the output of recombinant spider silk cocoons, these supporting vendors will play an essential role in processing that silk into finished goods for a wide range of consumer markets.

The Company plans to ship this Dragon Silk yarn to SpydaSilk Enterprises in Singapore, a joint venture partially owned by the Company for weaving into fabrics and finished garments. 

Over the coming months, Prodigy will continue to leverage this expanded silk production success to address the material needs of SpydaSilk and make additional materials available for purchase to fill the numerous and backlogged material requests it has received. 

 “The successful completing of this Dragon Silk yarn produced entirely utilizing the Vietnamese supply chain is a substantial achievement for the Kraig Labs and our vision for eco-responsible and cost-effective spider silk,” said COO Jon Rice. “I am extremely proud of the team at Prodigy for achieving this major milestone, while overcoming several obstacles to get this done as quickly as they did. 2022 is positioned to be a breakout year for the commercial sales of Dragon Silk and our broader recombinant spider silk technologies.”

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com


[1] https://inserco.org/en/statistics

This entry was posted on by .

Kraig Biocraft Laboratories Receives Equipment for Onsite Testing and Screening of Transgenic Technology at Prodigy Textiles

Onsite testing to enable significant production expansion

ANN ARBOR, Mich., – January 3, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces it has taken delivery of key lab equipment to Prodigy Textiles, the Company’s Vietnam based subsidiary, to support onsite testing and screening of spider silk transgenic technologies.

Over the next few weeks, the Company’s US-based research team will work closely with the Prodigy team to complete equipment installation and conduct training. Once online, this equipment will allow for the complete transfer of all genetic screening and selection testing, for production operations, to Prodigy’s onsite lab. 

The significance of this advancement in the Company’s production operation cannot be overstated. Previously all genetic testing was limited to Kraig Labs US R&D headquarters. COVID-related transportation and shipping restrictions over the last 24 months have meant that critical testing was delayed and, in some cases, not possible. This, in turn, forced the Company to lower its output at Prodigy to ensure production quality. With onsite process screening, Prodigy will be able to safely and effectively scale up operations and take full advantage of Prodigy’s new facilities. The goal is to run at maximum facility capacity consistently.   

Implementing in-process quality testing is yet another example of the Company’s efforts to build a completely autonomous production operation at Prodigy Textiles. The Company believes that, in blending the most advanced technologies available with the rich history of silk production in Vietnam, it is building an advanced scalable system for large-scale recombinant spider silk production.

“Once online, this equipment will allow our production team to floor the gas pedal on production,” said COO Jon Rice. “Travel and shipping delays in 2020 and 2021 demonstrated that Prodigy needed to have the tools in place to stand on its own. This onsite lab is the final element of that equation. In-process testing will give our team the tools and confidence needed to run our facilities at maximum capacity in very short order.”

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

This entry was posted on by .

Holiday Letter from Kraig Labs

With the holiday season upon us, I’d like to reach out to all of our team members, especially our shareholders, to express my appreciation and great expectations for our production and commercialization in 2022.

Yes, the holidays are just around the corner and we’re heading into 2022 in what is, by far, our strongest financial and fundamental position, so we’re excited about the coming advancements for Kraig Labs and anticipate spider silk’s commercial success in the New Year.

As you know, 2021 presented many new challenges, mostly centered on navigating the COVID-19 regulations, but addressing these with smart solutions has enriched Kraig and Prodigy Textiles, our Vietnamese subsidiary.

For example, after confirming proof of our production concept, we introduced the first automation into Prodigy’s workflow five months ago. This equipment has drastically improved our material handling and has allowed us to grow the size of our silkworm colony without bringing in additional labor.  More importantly, this equipment is playing a key role in our quality control system and is the backbone on which we are building out our production capacity.  This upgrade to our operations has delivered a sustained quality to our silkworm colony that was previously not attainable.

However, the next phase of this initiative is a game-changer; Prodigy’s fully equipped laboratory is a new onsite capacity that was designed to mirror the capabilities of Kraig’s US R&D headquarters and provide in-process quality and genetic screening. Partnered with the automated production equipment, the new lab will provide Prodigy with the same world-class genetic screening capabilities that were critical in Kraig’s creation of spider silk transgenics.  Once these capabilities are online, we anticipate judiciously scaling output to metric tons.

I believe that the importance of that milestone cannot be overstated, because it positions us to move on to the next chapter of our business model. Fulfilling the years’ long material request backlog which is key to securing additional commercialization agreements. Plus, we plan on working with some inventors and product developers whose imagination may take spider silk to yet unknown frontiers.

Dr. Miller, who completed his Ph.D. and postdoctoral work at Yale, joined Kraig’s R&D team in July. He’s already made significant contributions in advancing the commercialization of the Company’s new lines of nearly pure spider silk and the silkworm immunity enhancement program.   Dr. Miller has recharged our R&D team with new energy and expertise.  His contributions and ideas have opened the potential for several additional revenue streams reaching far beyond textiles.  We’re excited to see what he unveils over the next year.

Of course, most of these breakthroughs were made possible by the $5 million funding that the Company secured through its partnering with a substantial investment bank based in New York.  This marks the largest capital investment in the Company’s history.  Drawing this type of attention and confidence from sophisticated investors is exciting and reaffirming of our belief in the markets for spider silk and the future of Kraig Labs.    As our production operations continue to grow, we are positioned to see additional potential institutional funding in 2022.

Kraig Labs and Prodigy Textiles kindly thank you for your trust and continuing support, because we accomplished so much, together. We hope that you are surrounded by loved ones this holiday season and that, like Kraig, your best days remain ahead.

With warmest holiday greetings and best wishes for the New Year, 

Kim Thompson and the entire Kraig Labs’ family

This entry was posted on by .

Kraig Biocraft Laboratories Spider Silk Featured on BBC Earth series

Jon Rice, COO, Interview Clips included in the Broadcast

ANN ARBOR, Mich., – December 10, 2021 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces today that its spider silk was featured in a new episode of the BBC Earth’s “Inspired By Nature” series. 

To view a portion of the episode, please go to BBC Earth’s Facebook page and look for the “Bulletproof material made from a spider’s web” post at: https://www.facebook.com/bbcearth/videos/427557478860613/

 “We don’t need to reinvent the wheel, we don’t need to try to do something better than nature has, we simply need to find ways to reproduce what nature has already done,” said Jon Rice to BBC Earth when asked where Kraig Labs draws its inspiration.

Sample images of the Company’s recombinant spider silk silkworms and materials featured in the episode found on the Company’s website at www.kraiglabs.com/InspiredByNature

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About BBC Earth

Celebrating nature, science, space and the human race, BBC Earth brings you face to face with heart-pounding action, mind-blowing ideas and the sheer wonder of being part of this amazing planet we call home.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories Expands Production Footprint Building Self Reliant Supply Chain

Prodigy Textiles building out onsite mulberry production

ANN ARBOR, Mich., – December 9, 2021 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces today that it is expanding the footprint of its Vietnam based operations with the planting of several acres of mulberry trees at its recombinant spider silk production campus.  

Agricultural production cycles in Vietnam have historically left the Company with limited access and high costs for the continuous supply of fresh mulberry needed during the winter months.  With the expansive lands available in its new operations headquarters, Kraig Labs has begun planting mulberry on the more than 7 fertile acres located on the Campus of Prodigy Textiles, the Company’s Vietnamese based subsidiary. 

The Company will continue to partner with local farming cooperatives to source the majority of its mulberry during the summer months.  However, these onsite fields will eliminate the need for seasonal slowdowns that have impacted winter production.  Previously, the Company was forced to purchase mulberry from the broader markets.  Direct control over its own mulberry fields will remove concerns of pesticide overspray from adjoining farms that have been difficult to monitor in previous winters.

“Kraig Labs has always prided itself on being scrappy and self-reliant. Our team at Prodigy Textiles is no different.  The move to this new larger facility and these mulberry fields will allow us the ability to create a truly self-sustaining spider silk production campus,” said COO Jon Rice. “The final piece of this equation will be the lab equipment scheduled for installation later this month.  With that, Prodigy Textile will have the means, ability, and facilities to stand on its own as the world’s first truly sustainable supplier of spider silk super fibers.”

Sample images of the new production campus and the mulberry fields can be found on the Company’s website at www.kraiglabs.com/MulberryFields

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories Begins Production of Fourth Generation Recombinant Spider Silk Silkworms in New Production Headquarters

ANN ARBOR, Mich., – December 2, 2021 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces today that it has begun production of the fourth generation of its specialized spider silk silkworms at its new production campus.

Having successfully completed the third generation of silkworms in mid-November, the Company continues to grow the size and strength of its silkworm colony as it presses forward with continuous production operations.  Since transitioning all of its operations to this campus, in August of this year, the Company has increased the size of each successive production run and has seen a significant improvement in production yields.

Kraig Labs relocated Prodigy, the Company’s Vietnamese subsidiary, to this new facility in the heart of one of Quang Nam’s agricultural districts to leverage better access to fresh mulberry and the temperate climate.  Covering nearly 10 acres, this campus includes multiple buildings, including a dedicated laboratory, a separate rearing house built explicitly for silk production, and more than 7 acres of fertile land for onsite mulberry production.  

As the Company continues to grow its operational capacity, its existing supply of raw silk yarn is slated for spinning into custom yarns and composite fabrics that it will sell under its joint venture SpydaSilk brand.  The Company is currently assessing a number of potential textile mill partners to produce these fabrics as it works within the capacity limitations and lingering worker shortages imposed by COVID-19 restrictions.  

“With the beginning of fourth-generation production at the new campus, we are exactly where we need to be,” said COO Jon Rice.  “The measured and staged growth plan that we have put in place for this new facility has proven to be incredibly effective, resulting in consistent and reliable capacity expansion.   Later this month, we will begin the next evolution of our operation with the opening of the onsite laboratory.  This new lab will allow for in-process genetic screening and the tools to immediately increase our output by at least ten times and our vision of metric ton scale spider silk production.”

Sample images of the new production campus and third-generation silkworms in production can be found on the Company’s website at www.kraiglabs.com/prodigyHQ.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com


 [B1]Let’s include a live link

This entry was posted on by .

Kraig Biocraft Laboratories Resumes Work Producing Custom Spider Silk Yarns and Fabrics with Vietnam Re-opening

ANN ARBOR, Mich., – October 28, 2021– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, shares today that easing travel restrictions and re-opening business operations throughout Vietnam has re-energized the Company as it moves forward with the production of finished goods utilizing its specialized recombinant spider silk.

Safety protocols and restrictions enacted at the onset of the COVID-19 pandemic in Vietnam led to closures and slowdowns of many businesses throughout the country, most notably in Ha Noi and Ho Chi Minh City.  The majority of these restrictions did not directly impact the Company’s subsidiary, so Prodigy Textiles, located in central Vietnam, did not stop the production of its specialized silkworms. However, those shutdowns affected Prodigy’s employees and the Company, including delayed laboratory equipment deliveries, which delayed operational growth, and slowdowns at yarn spinners and weavers, which limited the Company’s ability to convert its raw silk into finished fabrics and garments. 

Now, as these restrictions are lifting, Kraig Labs is ready to accelerate the scale-up of silkworm production with the scheduled delivery and installation of new quality control (“QC”) lab equipment.  In the absence of the genetic screening that this new QC lab equipment will enable, the Company intentionally maintained production below peak capacity to ensure a stable and healthy silkworm colony.  Once installed, Prodigy’s facility will have onsite control systems far more advanced than nearly all silk producers.

This month brought several significant regulatory orders easing those restrictions, once again allowing the movement and travel for crucial goods, services, and personnel throughout the country.  With the re-opening of textile mills and yarn spinners, Kraig Labs is now resuming work to produce the custom yarns and spider silk fabrics for the launch of SpydaSilkTM apparel, a joint development partnership with Kings Golden Harvest, PTE LTD.  

“We are pleased to see conditions in Vietnam improving for its people and its economy,” said Kraig Labs COO Jon Rice.  “In the coming weeks, we expect to receive and install several pieces of lab equipment delayed due to lockdowns.  This quality assurance equipment will play a key role in our continued production expansion.  Most critically, with this re-opening, we can once again work with the textile mills to weave our silk into the finished fabrics for the first garments for SpydaSilk and to supply materials to the numerous other brands eager to incorporate spider silk into their products.” 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

This entry was posted on by .

Challenge Testing of Kraig Biocraft Laboratories’ Disease Resistant Silkworms Underway

Immunity enhanced silkworms provide licensing opportunities into the broader $14 B[1] silk industry

ANN ARBOR, Mich., – October 19, 2021– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces today that it has begun challenge testing on of its immunity enhanced silkworms. These silkworms were developed by Kraig Labs to combat viral and fungal infections that result in significant losses in global silk production.  

As much as 50% of losses in global silk production are the result of a single virus. Up to 75% of all silk producers have reported losses from this virus, according to a 2020 research paper. These losses account for millions and potentially billions of dollars of lost economic production each year. Often found in soil and plants – quickly spread and with no effective treatment – this virus can be devastating to small and large producers alike.  With this announcement, Kraig Labs is creating a solution for the global $14B silk market. 

By adapting its genetic engineering technologies, used to produce recombinant spider silk, Kraig Labs has developed multiple lines of silkworms that incorporate a genetic defense against this virus and other prominent silkworm diseases. As designed, the silkworm’s immune system will target and eliminate any copy of the virus DNA, preventing the spread of infection and loss.

Having built a sizeable colony of these immunity-enhanced silkworms, the Company is now undergoing challenge testing at a controlled offsite test location. This remote offsite location was selected to prevent the potential introduction and spread of the virus into Kraig Labs R&D headquarters.

These new disease-resistant silkworms are intended for licensing into the global market for mundane silks to combat key pathogenic viruses and fungi. The Company expects to make these lines of resilient silkworms available for commercial licensing upon the conclusion of successful challenge testing and intends to incorporate this technology into all of its lines of spider silk transgenics.

“With testing now underway, we are excited to see the potential that these new silkworm strains can bring to the broader sericulture industry,” said the Company’s COO, Jon Rice. “Combating these silkworm diseases is an industry-wide challenge.  Bringing licensable, immunity-enhanced silkworms to the global silk market advances our business model and aligns with our core focus in commercializing cost-effective and environmentally responsible recombinant spider silk.” 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com


[1] From New Analysis from Global Industry Analysts Reveals Steady Growth for Silk, with the Market to Reach $21 Billion Worldwide by 2026, read more at: https://www.prnewswire.com/news-releases/new-analysis-from-global-industry-analysts-reveals-steady-growth-for-silk-with-the-market-to-reach-21-billion-worldwide-by-2026-301377060.html

This entry was posted on by .

Kraig Biocraft Laboratories Announces Breakthrough in Creation of New Recombinant Spider Silks

Kraig Labs files provisional patent for next-generation gene-editing system

ANN ARBOR, Mich., – October 12, 2021– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces today that its research team has surpassed a crucial milestone in the creation and production of new recombinant spider silks and other key target proteins. The Company is now raising several batches of first-generation transgenics utilizing this new and more efficient process. 

These transgenics represent the first implementation of this new knock-out/knock-in multiplex system for silkworms developed by Kraig Labs’ research team.  The new approach results in a greater than 60% reduction in process complexity when creating new transgenics and should result in significantly higher yields.  Pairing multiplex targeting with co-expression of trans-proteins, this new system should allow the Company to achieve homozygous, germline stable, new transgenics in a fraction of the time. 

Kraig Labs’ research team will monitor these first-generation transgenics over the next 30 days to verify improvements over existing systems. The Company’s research team has already prepared and filed a potential provisional patent to protect this new novel technology. 

“Today’s announcement is just the latest in a string of incredible breakthroughs from our research lab.  Our team continues to defy conventional wisdom, finding almost unimaginable solutions and unlocking the potential for cost-effective, commercial-scale spider silk production,” said COO Jon Rice.  “This breakthrough is the direct result of our exceptionally creative research team.   Through an intentional process of seeking out diverse backgrounds and experiences for all positions throughout the organization, we have built a truly extraordinary team.”

While now focused on improving the production of recombinant spider silk, this new gene system is directly applicable to the Company’s accelerating work in non-fibrous and boutique protein production. 

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

This entry was posted on by .